landmark NIH hypertension study will change how patients with high blood pressure are treated
January 2003
New results from the landmark NIH hypertension study will change how patients with high blood pressure are treated.
Currently, most hypertension patients start on an ACE inhibitor, beta-blocker, or calcium channel blocker.
A thiazide diuretic is often added when extra blood pressure control is needed.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote